Teleflex Incorporated Plans Quarterly Dividend of $0.34 (NYSE:TFX)

Teleflex Incorporated (NYSE:TFX) announced a quarterly dividend on Thursday, February 27th, RTT News reports. Shareholders of record on Friday, March 7th will be given a dividend of 0.34 per share by the medical technology company on Monday, March 17th. This represents a $1.36 dividend on an annualized basis and a yield of 0.77%.

Teleflex has a payout ratio of 8.2% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Teleflex to earn $15.18 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 9.0%.

Teleflex Stock Down 0.1 %

Shares of NYSE TFX opened at $177.45 on Thursday. The business has a 50-day moving average of $177.07 and a two-hundred day moving average of $206.17. The company has a market capitalization of $8.24 billion, a price-to-earnings ratio of 35.28, a price-to-earnings-growth ratio of 1.73 and a beta of 1.16. Teleflex has a 1 year low of $165.62 and a 1 year high of $249.90. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping the consensus estimate of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. On average, analysts forecast that Teleflex will post 13.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently commented on TFX shares. Truist Financial dropped their target price on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. StockNews.com raised Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Royal Bank of Canada reduced their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Finally, Mizuho cut their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, November 1st. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, Teleflex has an average rating of “Moderate Buy” and an average price target of $246.00.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.